| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VRTX | Common Stock | Sale | -$1.62M | -4.65K | -9.61% | $349.48 | 43.7K | May 2, 2023 | Direct | F1, F2, F3 |
| transaction | VRTX | Common Stock | Sale | -$527K | -1.51K | -3.44% | $350.48 | 42.2K | May 2, 2023 | Direct | F1, F2, F4 |
| transaction | VRTX | Common Stock | Sale | -$106K | -300 | -0.71% | $353.18 | 41.9K | May 2, 2023 | Direct | F1, F2, F5 |
| transaction | VRTX | Common Stock | Sale | -$701K | -2.01K | -4.79% | $349.22 | 39.9K | May 3, 2023 | Direct | F1, F2, F6 |
| transaction | VRTX | Common Stock | Sale | -$631K | -1.8K | -4.51% | $350.53 | 38.1K | May 3, 2023 | Direct | F1, F2, F7 |
| transaction | VRTX | Common Stock | Sale | -$246K | -700 | -1.84% | $351.59 | 37.4K | May 3, 2023 | Direct | F1, F2, F8 |
| holding | VRTX | Common Stock | 440 | May 2, 2023 | 401(k) |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 11/01/2022. |
| F2 | Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| F3 | Open market sales reported on this line occurred at a weighted average price of $349.48 (range $349.00 to $349.99). |
| F4 | Open market sales reported on this line occurred at a weighted average price of $350.48 (range $350.08 to $351.01). |
| F5 | Open market sales reported on this line occurred at a weighted average price of $353.18 (range $352.63 to $353.53). |
| F6 | Open market sales reported on this line occurred at a weighted average price of $349.22 (range $349.00 to $349.94). |
| F7 | Open market sales reported on this line occurred at a weighted average price of $350.53 (range $350.08 to $350.90). |
| F8 | Open market sales reported on this line occurred at a weighted average price of $351.59 (range $351.33 to $352.02). |